OMass Therapeutics, Ltd

“As economic, social, and environmental crises magnify, the world is undergoing some of the most turbulent times we’ve ever seen,” observed Emmanuelle Quilès , worldwide vice president, cardiovascula

“Pharma, like all industries, has a responsibility to protect and enhance the environment. Our sector’s commitment takes on added significance given our role in improving people’s health.” These words

Venture capital fundraising by biopharmaceutical firms in the second quarter was a mixed bag, according to Venture Monitor data from Pitchbook and the National Venture Capital Association (NVCA), wh